{"product_id":"alliar-five-forces-analysis","title":"Alliar Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDon't Miss the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAlliar’s Porter's Five Forces snapshot highlights moderate buyer power, concentrated supplier influence in medical tech, low threat of new entrants but rising substitutes from telemedicine, and intense competitive rivalry among imaging providers.\u003c\/p\u003e\n\u003cp\u003eThis brief preview only scratches the surface — unlock the full Porter's Five Forces Analysis to explore force-by-force ratings, visuals, and actionable implications to inform investment and strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of medical equipment manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe diagnostic imaging sector relies on a few global vendors—GE Healthcare, Siemens Healthineers, Philips—giving suppliers strong leverage over Alliar because MRI\/CT machines (capex per unit often $1–5M) are essential and hard to replace.\u003c\/p\u003e\n\u003cp\u003eBy end-2025, AI-integrated hardware and proprietary maintenance\/software updates heighten dependence; industry reports show 60–70% of vendors’ service revenue tied to software, limiting Alliar’s price negotiation and raising obsolescence risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScarcity of specialized medical professionals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe supply of qualified radiologists and specialized technicians in Brazil is tight versus demand for advanced diagnostics; Brazil had about 9 radiologists per 100,000 people in 2023, below OECD peers, boosting supplier leverage. These clinicians control report accuracy and reputation, so Alliar must offer competitive pay—median radiologist salaries rose ~12% in 2022–24—and modern equipment to retain staff. Labor shortages cut throughput, raising per-scan costs and delaying revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal supply chain for reagents and consumables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClinical analysis labs need steady imports of reagents and disposables; about 60–70% of Alliar’s key reagents were imported in 2024, so exchange-rate swings (BRL fell ~12% vs USD in 2024) raised input costs materially.\u003c\/p\u003e\n\u003cp\u003eGlobal logistics disruptions (Suez delays, airfreight rates up 35% in 2021–24) and supplier long-term contracts with minimums reduce Alliar’s buying flexibility and raise working-capital needs.\u003c\/p\u003e\n\u003cp\u003eBrazilian localisation efforts cut import dependence to roughly 40% by late 2025, but domestic capacity covers mainly low-margin disposables, so global suppliers still set prices for specialized reagents.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependency on specialized IT and software providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eModern diagnostics depend on PACS (Picture Archiving and Communication Systems) and LIS (Laboratory Information Systems), which create high switching costs—industry reports show hospital IT replacement can cost 5–15% of annual revenue and take 6–18 months.\u003c\/p\u003e\n\u003cp\u003eVendors hold power via required continuous support, cybersecurity updates (average breach cost $4.45M in 2023), and rising fees as Alliar shifts to cloud and AI tools.\u003c\/p\u003e\n\u003cp\u003eThe need for data security and interoperability gives suppliers pricing leverage and strategic influence as partners.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh switching costs: 6–18 months, 5–15% revenue\u003c\/li\u003e\n\u003cli\u003eCyber breach avg cost: $4.45M (2023)\u003c\/li\u003e\n\u003cli\u003eCloud\/AI adds vendor dependency\u003c\/li\u003e\n\u003cli\u003eInteroperability raises supplier leverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReal estate and strategic location providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePhysical presence in affluent, high-traffic urban areas drives patient volume; landlords in São Paulo and Rio de Janeiro command premiums—central São Paulo office rents rose ~12% in 2024, raising occupancy costs for Alliar (diagnostics chain with ~220 units as of Dec 2024).\u003c\/p\u003e\n\u003cp\u003eRelocation is costly due to heavy imaging equipment: de-install\/re-install can exceed BRL 1–3 million per large site, giving landlords leverage and constraining Alliar’s expansion when suitable spaces are scarce.\u003c\/p\u003e\n\u003cp\u003eAlliar uses long-term leases; renewals in competitive metro markets can spike rents by 10–30%, pressuring margins and capital allocation.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePrime location rents up ~12% in 2024 (São Paulo)\u003c\/li\u003e\n\u003cli\u003eRelocation cost BRL 1–3M per large site\u003c\/li\u003e\n\u003cli\u003eAlliar had ~220 units (Dec 2024)\u003c\/li\u003e\n\u003cli\u003eRenewal rent increases typically 10–30%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier dominance, FX \u0026amp; talent squeeze threaten Alliar’s margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong power: few global vendors (GE, Siemens, Philips) dominate capital equipment (MRI\/CT $1–5M), software\/service revenue 60–70% by 2025, high switching costs (6–18 months; 5–15% revenue), and reagent imports ~40–70% (60–70% in 2024) raise FX exposure; radiologist scarcity (≈9\/100k in 2023) and rising rents\/relocation costs (BRL 1–3M) further squeeze Alliar.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVendor service rev\u003c\/td\u003e\n\u003ctd\u003e60–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReagent imports (2024)\u003c\/td\u003e\n\u003ctd\u003e60–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRadiologists\/100k (2023)\u003c\/td\u003e\n\u003ctd\u003e≈9\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSwitch cost\u003c\/td\u003e\n\u003ctd\u003e6–18 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Alliar, this Porter’s Five Forces analysis uncovers key drivers of competition, supplier and buyer influence, entry barriers, and disruptive substitutes that shape its market position and profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Alliar Porter’s Five Forces one-sheet highlighting competitive pressures and bargaining power to speed clear, board-ready decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of private health insurance payers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa large share of alliar revenue comes from private insurers that have consolidated sa and amil together control about market premiums by them strong leverage to set exam reimbursement rates. late these pushed deeper discounts curb rising medical loss ratios with negotiated price cuts reported across diagnostic providers. must balance margin preservation against the need remain in dominant networks keep patient volumes revenue.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVerticalization of healthcare providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge insurers like Bradesco Saúde and SulAmérica have expanded in-house labs and imaging, cutting referrals to independents such as Alliar; in Brazil insurer-owned diagnostics grew ~18% CAGR 2019–2024, reducing external volume by an estimated 10–20% for some chains.\u003c\/p\u003e\n\u003cp\u003eAs insurers steer patients to proprietary sites, bargaining power shifts to payers; Alliar must prove superior quality metrics (e.g., shorter TAT, lower recall rates) or local convenience to retain contracts and volumes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice sensitivity of out-of-pocket patients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOut-of-pocket patients show high price and convenience sensitivity for routine tests; surveys in Brazil (IBGE, 2023) report 62% compare lab prices before choosing a provider. Patients switch for promotions or easier apps—online bookings lifted market share for digital-first labs by ~15% in 2024. Alliar must reconcile its premium imaging positioning with competitive pricing and app UX in clinical analysis to retain price-conscious consumers. With real wages down 1.2% YoY in 2024, consumer switching keeps pricing pressure on Alliar.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and public sector influence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAlliar mainly serves private clients, but government contracts shift power: the Brazilian federal and state health systems can impose strict price ceilings and extended payment terms that compress margins versus private-pay rates.\u003c\/p\u003e\n\u003cp\u003ePublic policy changes and expansion of SUS (Sistema Único de Saúde) diagnostic capacity lower private demand; in 2024 SUS accounted for ~45% of imaging volume nationally, pressuring private labs.\u003c\/p\u003e\n\u003cp\u003eANS regulation (National Supplementary Health Agency) adds billing and authorization rules for private insurers, complicating reimbursements and increasing compliance costs for Alliar.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGovernment as buyer: sets price ceilings, long payment terms\u003c\/li\u003e\n\u003cli\u003e2024 SUS share: ~45% of imaging volume (national)\u003c\/li\u003e\n\u003cli\u003ePublic expansion reduces private demand\u003c\/li\u003e\n\u003cli\u003eANS rules raise billing complexity and compliance costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInformed consumers and digital transparency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy 2025 patients use platforms showing quality scores and reviews—NPS and online ratings often shift choice: 68% of Brazilian patients check reviews before diagnostics (2024 IBGE\/OpinionBox); this raises customer bargaining power versus Alliar.\u003c\/p\u003e\n\u003cp\u003eAlliar needs targeted spend: estimate 3–5% revenue on digital UX and patient experience to protect retention; one bad viral review can cut referrals by 12% within 30 days.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e68% check reviews (2024)\u003c\/li\u003e\n\u003cli\u003e3–5% revenue for digital\/patient experience\u003c\/li\u003e\n\u003cli\u003e12% referral drop after viral complaint\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyers squeeze Alliar: insurers \u0026amp; SUS cut prices, digital spend vital (3–5% revenue)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpbuyers insurers and the public sus strong leverage over alliar with bradesco sa controlling premiums of imaging volume driving negotiated price cuts in squeezing margins insurer-owned diagnostics grew cagr reduced external volumes patients increasingly compare prices check pressuring pricing ux should target revenue for digital experience.\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBradesco+Amil market share\u003c\/td\u003e\n\u003ctd\u003e40–50% (2024–25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSUS imaging share\u003c\/td\u003e\n\u003ctd\u003e~45% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInsurer-owned diagnostics CAGR\u003c\/td\u003e\n\u003ctd\u003e~18% (2019–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNegotiated cuts (2025)\u003c\/td\u003e\n\u003ctd\u003e5–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatients checking reviews\u003c\/td\u003e\n\u003ctd\u003e68% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecommended digital spend\u003c\/td\u003e\n\u003ctd\u003e3–5% revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/pbuyers\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eAlliar Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Alliar Porter’s Five Forces analysis you’ll receive after purchase—no samples, no placeholders, fully formatted and ready to download for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747468652921,"sku":"alliar-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/alliar-five-forces-analysis.png?v=1772198897","url":"https:\/\/matrixbcg.com\/products\/alliar-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}